NutraLife BioSciences, Inc.
NLBS
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -30.83% | 16.95% | 39.42% | -160.02% | 61.99% |
| Total Depreciation and Amortization | -0.45% | -10.64% | 62.86% | -12.61% | 4.18% |
| Total Amortization of Deferred Charges | -10.00% | -47.11% | -28.89% | 20.63% | 0.52% |
| Total Other Non-Cash Items | 60.70% | -21.40% | -53.24% | 706.08% | -89.67% |
| Change in Net Operating Assets | -93.60% | 391.45% | -104.23% | 3,031.10% | -80.35% |
| Cash from Operations | -77.28% | 45.23% | -196.04% | 243.09% | -20.63% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -7.41% | -- | -- |
| Cash from Investing | -- | 100.00% | -7.41% | -- | -- |
| Total Debt Issued | -169.73% | 1,852.00% | -69.43% | -28.54% | -- |
| Total Debt Repaid | -192.69% | -5.48% | -1,073.81% | 12.50% | 5.88% |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -19.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 342.05% | -200.00% | -- | -- | -- |
| Cash from Financing | 447.41% | -78.04% | 428.17% | -53.45% | 138.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,944.62% | 91.61% | -1,562.26% | -95.50% | 237.78% |
